Axogen Corporation
Clinical trials sponsored by Axogen Corporation, explained in plain language.
A medical device company focused on peripheral nerve repair and regeneration.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Nerve cap aims to ease pain after limb loss Results expected Dec 2026 (estimated)
- New wrap may shield nerves during second elbow surgery Results expected Dec 2026 (estimated)
-
Nerve graft registry tracks recovery in thousands of patients
Disease control OngoingThis study follows over 3,000 people who received the Avance Nerve Graft to repair damaged peripheral nerves. Researchers are tracking safety, sensory and motor function recovery, and quality of life in real-world settings. The goal is to understand how well this processed human …
Sponsor: Axogen Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
Nerve cap aims to ease pain after limb loss
Symptom relief OngoingThis study tests a special nerve cap (Axoguard Large-Diameter Nerve Cap) in 15 adults who have had a limb injury or amputation. The cap is placed over the cut nerve end to protect it and may help reduce chronic nerve pain. The goal is to see if the cap is safe and works well befo…
Sponsor: Axogen Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New wrap may shield nerves during second elbow surgery
Symptom relief OngoingThis study looks at whether a special nerve wrap can help people who need a second surgery for cubital tunnel syndrome, a condition where a nerve in the elbow gets compressed. Twenty adults with ongoing pain or numbness after their first surgery will receive the nerve protector d…
Sponsor: Axogen Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC